Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FZC49
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,670
Award facts
- Contract value 100% obligated
- $29,669.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $29,669.58 to DMS Pharmaceutical Group Inc. for the supply of Entyvio 300 mg vials. The contract, issued on August 4, 2025, with an ultimate completion date of August 25, 2025, represents a specific purchase order fulfilling pharmaceutical supply requirements for federal healthcare operations. This delivery order is issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned small business.
DMS Pharmaceutical Group Inc., based in Park Ridge, Illinois, is executing this delivery order under its larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 and valid through November 2026. As a pharmaceutical wholesaler specializing in federal supply chains, the company provides a comprehensive portfolio of branded and generic prescription drugs, biologics, and medical consumables to military and Department of Defense healthcare facilities. This delivery order for Entyvio, a specialty biologic medication, aligns with the company's established role as a critical supplier within the federal pharmaceutical distribution network supporting military health system requirements.
Quick answers
Who was awarded contract SPE2DB25FZC49?
SPE2DB25FZC49 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 4, 2025.
How much is contract SPE2DB25FZC49 worth?
The government has obligated $29,670 on SPE2DB25FZC49.
Is contract SPE2DB25FZC49 an order under another contract?
Yes. SPE2DB25FZC49 is a delivery order under SPE2DB22D9143, an indefinite delivery contract.
Was contract SPE2DB25FZC49 competed?
The extent of competition for SPE2DB25FZC49 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award